TIGEM Technologies impact in the gene therapy landscape: watch an interview to Alberto Auricchio on Ellisir (RAI 3)
Feb 05, 2024
Gene therapy is experiencing a groundbreaking revolution in the treatment of hereditary deafness, thanks to the pioneering work of Dr. Alberto Auricchio and his team at the Telethon Institute of Genetics and Medicine (Tigem). Their innovative dual vector technology is at the forefront of two transformative clinical trials that have the potential to change the lives of millions affected by hereditary hearing impairments.
Don't miss the opportunity to tune in for the interview with Alberto Auricchio on the topic this 7th February at 10:35 @ Elisir (RAI 3)
Don't miss the opportunity to tune in for the interview with Alberto Auricchio on the topic this 7th February at 10:35 @ Elisir (RAI 3)